AstraZeneca's ( ) flagship health equity programme - Healthy Heart Africa (HHA), marks its 10th anniversary, celebrating successfully ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 78 tables and 119 figures, this 215-page report ?Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...
Daily Independent on MSN10d
AstraZeneca reaffirms commitment to cancer care on World Cancer Day 2025In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...
17h
Sumitomo Mitsui Trust Group Inc. grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities & ...
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
Stephens Inc. AR lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.2% in the fourth quarter, Holdings Channel reports. The fund owned 24,987 shares of the company’s ...
AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...
Liverpool Echo on MSN9d
Keir Starmer says AstraZeneca move to scrap Speke investment was 'commercial decision'Prime Minister Keir Starmer said it was a “commercial decision” by a major international biopharmaceutical firm to pull out ...
As a global biopharmaceutical company with a strong commitment to oncology care, AstraZeneca continues to champion oncology efforts by focusing on early detection, patient advocacy, and equitable ...
Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company's standalone net profit surged to Rs 54.68 crore in Q3 FY25 as compared with Rs 15.80 crore in Q3 FY24.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback